Table of Contents
ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Major Findings of the Report
India in Context – A Rapidly Developing Economy with Major Demographic
Challenges
Demographic Aging
Disease Drivers
Infectious Disease Threats
Indian Economy
IVD Market in the BRIC Countries
IVD Market in India
SWOT Analysis
Leading Players
TWO: INTRODUCTION TO HEALTH CARE AND DIAGNOSTICS IN THE DEVELOPING WORLD – INDIA IN CONTEXT
Background
Population Trends and Disease Demographics
Obesity
Disease Trends
Diabetes
Cancer
Allergy and Asthma
Cardiovascular Disease
Emerging Viruses and Diseases
Antimicrobial Drug Resistance
Clinical Lab Tests
Types of Tests
Venues for Test Usage
Market Segment Opportunities
Point-of-Care (POC) Testing
Core Lab Tests
Molecular Assays
Hematology
Coagulation
Microbiology
Tests Used in Blood Banking
Histology and Cytology
The Future of Indian Economic Growth
Rising Standards of Living
Young, English-Speaking Labor Force
Corruption and Bribery
Exchange Rate
BRIC Metrics – Indian IVD Market in Context
Available Markets – Urban Populations in BRIC Countries
Paying for Healthcare – Government Expenditures and the Culture of Spending
Healthcare Capacities in BRIC Nations – A Work in Progress
IVD Spending
THREE: INDIA IVD SWOT ANALYSIS
Introduction
Strengths – Conditions That Support Market Growth
Government Support of the Emerging Indian Healthcare Market
Expanding Medical Education
Increasing Health Insurance Penetration
Improving Intellectual Property Protection
Thriving Biotech Industry
Contract Research and High Technology
Returning Scientists
Growing Hospital Sector
Expanding Clinical Labs
Medical Tourism
Strong IT Sector
Weaknesses – Factors That Pose Barriers to Market Success and Entry
Traditional Medicine
Resource Constraints in Hospitals
Culture and Business Environment
Quality and Safety Concerns
Lack of Medical Device and Diagnostics Regulation
Lack of IVD R&D
High Out of Pocket Consumer Expenditures
Healthcare Pricing
Opportunities – Rural Healthcare and Technology Partnerships
Threats – Domestic and Chinese Competition
Domestic Competition
Chinese Competition
FOUR: INDIA IVD MARKET SIZE
Introduction
The Market
Total Indian IVD Market
Immunoassays
Clinical Chemistry
Hematology
Point of Care/OTC
Molecular
Urinalysis
Other IVD Tests
FIVE: INDUSTRY AND COMPANY ACTIVITY IN INDIA
Introduction
Market Leaders in India
Indian IVD Players
International IVD Companies – Recent Activity
Abbott Laboratories
Affymetrix, Inc.
Alere
Arkray
Beckman Coulter, Inc./Danaher
Becton, Dickinson & Co
Biohit Oy
bioMérieux, Inc.
Bio-RAD Laboratories, Inc.
Daan Gene Co., Ltd.
Danaher Corp.
Gen-Probe, Inc.
Grifols
Hologic, Inc.
Horiba Medical
Instrumentation Laboratory
Laboratory Corporation of America
Luminex Corporation
MedMira
Mindray Medical International, Ltd.
Myriad Genetics
Ortho Clinical Diagnostics
PerkinElmer
Promega Corporation
QIAGEN N.V.
Quest Diagnostics
Radiometer A/S
Roche
Shanghai Fosun Pharmaceutical Co. Ltd.
Shanghai Kehua Bio-engineering
Siemens
SRL Diagnostics
Sysmex Corp.
Thermo Fisher Scientific
LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Exhibit 1-1: Global Map of India
Table 1-1: BRIC IVD Markets by Country, 2015 – 2020
Table 1-2: IVD Sales in India by Market Segment (Immunoassays, Clinical
Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
Table 1-3: Indian IVD Growth Rates of Market Segments (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other), 2015-2020,2015-2025 and 2020-2025
Exhibit 1-2: IVD Market Share in India by Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015, 2020 and 2025
Exhibit 1-3: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015, 2020 and 2025
Exhibit 1-4: Indian Life Expectancy by State, 2014
TWO: INTRODUCTION TO HEALTH CARE AND DIAGNOSTICS IN THE DEVELOPING WORLD – INDIA IN CONTEXT
Table 2-1: Elderly Support Ratio in India, Other BRIC and Selected Countries(2010/2050) (Niger, Uganda, Pakistan, India, Egypt, Guatemala, Morocco, Mexico,Brazil, China, Russia, United States, France, Japan, World)
Table 2-2: Selected Worldwide Disease Statistics, 2015 (Respiratory Infections,Malaria, HIV/AIDS, Chlamydia, Gonorrhea, Maternal Conditions, Asthma,Cardiac Disease, Diabetes, Cancer, Syphilis, Tuberculosis, Hepatitis)
Exhibit 2-1: Diabetes Population by Country, 2015
Exhibit 2-2: Cardiovascular Disease Death as a Percentage of Total Deaths, 2015
Table 2-3: Types of IVD and Clinical Laboratory Tests, 2015
Table 2-4: Clinical Lab Counts and Lab Automation Penetration in BRIC Countries
Exhibit 2-3: Countries by Nominal per Capita GDP in 2014
Exhibit 2-4: Per Capita GDP by Indian Province in 2014
Exhibit 2-5: Linguistic Map of India
Table 2-5: Available (Urban) Market Development in BRIC Countries(2003/2015)
Table 2-6: Government and Total Health Expenditures in BRIC and Comparison Countries, 2013 (United States, France, Germany, Italy, Japan, United Kingdom,Australia, Brazil, South Africa, Argentina, South Korea, Vietnam, Poland,Turkey, Mexico, Russia, Nigeria, China, Thailand, India, Indonesia)
Table 2-7: Growth Rates of Government and Total Healthcare Expenditures and Real GDP (BRIC and Comparison Countries; 2003-2013) (India, Nigeria,Argentina, Vietnam, Indonesia, Turkey, Russia, Poland, Thailand, Brazil, South Korea, South Africa, Australia, Mexico, United States, Germany, United Kingdom, France, Japan, Italy)
Table 2-8: Healthcare System Capacities – BRIC and Comparison Countries (Argentina, Australia, Brazil, China, France, Germany, India, Indonesia, Italy, Japan, South Korea, Mexico, Nigeria, Poland, Russia, South Africa, Thailand,Turkey, United Kingdom, United States, Vietnam)
Table 2-9: Per Capita IVD Expenditures and IVD Markets by Country, 2015(United States, Japan, Germany, France, Italy, China, Spain, United Kingdom,Brazil, Russia, India)
Table 2-10: BRIC IVD Markets by Country, 2015 – 2020 ($ millions)
THREE: INDIA IVD SWOT ANALYSIS
Table 3-1: Cost Savings from Medical Tourism for Various Procedures, 2015(Rhinoplasty, Face-Lift, Breast Augmentation, Breast Reduction, Complete Liposuction, Gluteal Augmentation)
Exhibit 3-1: Ayurvedic Medicine Doshas
Exhibit 3-2: Ayurvedic Medicine vs. Western Medicine
Exhibit 3-3: Common Homeopathic Remedies
Table 3-2: Out-Of-Pocket, Other Private and Government Healthcare Expenditures in BRIC and Comparison Countries (% of Total Expenditures) (South Africa,France, United Kingdom, United States, Germany, Thailand, Turkey, Japan,Australia, Italy, Poland, Argentina, Brazil, South Korea, China, Russia, Mexico,Indonesia, Vietnam, India, Nigeria)
Table 3-3: Chinese IVD Companies
FOUR: INDIA IVD MARKET SIZE
Exhibit 4-1: Global IVD and Clinical Lab Market, 2015 (India, Russia, Brazil,United Kingdom, Spain, China, Italy, France, Germany, Japan, United States)
Exhibit 4-2: Global IVD and Clinical Lab Market, 2020 (India, Russia, Brazil,United Kingdom, Spain, China, Italy, France, Germany, Japan, United States)
Exhibit 4-3: Global IVD and Clinical Lab Market, 2025 (India, Russia, Brazil,United Kingdom, Spain, China, Italy, France, Germany, Japan, United States)
Table 4-1: Total IVD Sales in India, 2015-2025
Exhibit 4-4: Total IVD Sales in India, 2015-2025
Table 4-2: IVD Sales in India by Market Segment (Immunoassays, Clinical
Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
Exhibit 4-5: IVD Sales in China by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
Table 4-3: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2020
Exhibit 4-6: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2020
Table 4-4: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2025
Exhibit 4-7: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2025
Table 4-5: Immunoassay Sales in India, 2015-2025
Exhibit 4-8: Immunoassay Sales in India, 2015-2025
Table 4-6: Clinical Chemistry Sales in India, 2015-2025
Exhibit 4-9: Clinical Chemistry Sales in India, 2015-2025
Table 4-7: Hematology Sales in India, 2015-2025
Exhibit 4-10: Hematology Sales in India, 2015-2025
Table 4-8: Point of Care/OTC Sales in India, 2015-2025
Exhibit 4-11: Point of Care/OTC Sales in India, 2015-2025
Table 4-9: Molecular Test Sales in India, 2015-2025
Exhibit 4-12: Molecular Test Sales in India, 2015-2025
Table 4-10: Urinalysis Test Sales in India, 2015-2025
Exhibit 4-13: Urinalysis Test Sales in India, 2015-2025
Exhibit 4-14: uChek Urinalysis Test
Table 4-11: Other IVD Test Sales in India, 2015-2025
Exhibit 4-15: Other IVD Test Sales in India, 2015-2025
FIVE: INDUSTRY AND COMPANY ACTIVITY IN INDIA
Table 5-1: Leading Global IVD Companies in India
Table 5-2: Selected Domestic IVD Companies in India
